Soterius Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 8.50 M
- Paid Up Capital ₹ 4.50 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 25.87%
- Profit Growth 74.65%
- Ebitda 60.08%
- Net Worth 41.10%
- Total Assets 25.22%
About Soterius Life Sciences India
Soterius Life Sciences India Private Limited (SLSIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 26 December 2018 (Six years and two months 5 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.50 M and a paid-up capital of Rs 4.50 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Aggarwal, Sumit Verma, and Suneet Walia serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999DL2018FTC343480
- Company No.
343480
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
26 Dec 2018
- Date of AGM
20 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Soterius Life Sciences India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suneet Walia  | Director | 26-Dec-2018 | Current |
| Neeraj Aggarwal | Director | 28-Mar-2019 | Current |
| Sumit Verma | Whole-Time Director | 26-Dec-2018 | Current |
Financial Performance of Soterius Life Sciences India.
Soterius Life Sciences India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.87% increase. The company also saw a substantial improvement in profitability, with a 74.65% increase in profit. The company's net worth Soared by an impressive increase of 41.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Soterius Life Sciences India?
In 2022, Soterius Life Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bizxpert Valuation Services Private LimitedNeeraj Aggarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Soterius Life Sciences India?
Soterius Life Sciences India has a workforce of 41 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Soterius Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soterius Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
